Epigral's Strong Performance Highlights Resilience Amid Broader Market Challenges

Epigral, a midcap player in the chemicals industry, has shown significant activity today, gaining 5.46% on March 7, 2025. This performance has allowed the stock to outperform its sector by 4.48%. Over the past four days, Epigral has demonstrated a strong upward trend, accumulating a total return of 19.88%. The stock reached an intraday high of Rs 1880.95, marking a 6.4% increase during the trading session.
In terms of moving averages, Epigral's current price is above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. This indicates a mixed short-term trend in relation to longer-term performance metrics.

While the broader market, represented by the Nifty, closed at 22,552.50 with a slight increase of 0.03%, Epigral's performance stands out, particularly in the context of its year-to-date return of -1.88%, which is better than the Nifty's decline of 4.87%. Over the past year, Epigral has achieved a remarkable 64.25% increase, significantly outpacing the Sensex's modest gain of 0.29%.